Found: 18
Select item for more details and to access through your institution.
Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 3, p. 1, doi. 10.1007/s00432-024-05681-x
- By:
- Publication type:
- Article
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7539, doi. 10.1007/s00432-023-04702-5
- By:
- Publication type:
- Article
X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5531, doi. 10.1007/s00432-022-04476-2
- By:
- Publication type:
- Article
Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2287, doi. 10.1007/s00432-022-04025-x
- By:
- Publication type:
- Article
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 5, p. 1223, doi. 10.1007/s00432-021-03720-5
- By:
- Publication type:
- Article
MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 6, p. 1213, doi. 10.1007/s00432-016-2138-z
- By:
- Publication type:
- Article
Analyzing the Impact of Oncological Data at Different Time Points and Tumor Biomarkers on Artificial Intelligence Predictions for Five-Year Survival in Esophageal Cancer.
- Published in:
- Machine Learning & Knowledge Extraction, 2024, v. 6, n. 1, p. 679, doi. 10.3390/make6010032
- By:
- Publication type:
- Article
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25071-y
- By:
- Publication type:
- Article
Proposal for a definition of "Oligometastatic disease in pancreatic cancer".
- Published in:
- 2019
- By:
- Publication type:
- journal article
Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5881, doi. 10.3390/cancers15245881
- By:
- Publication type:
- Article
Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2049, doi. 10.3390/cancers15072049
- By:
- Publication type:
- Article
Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2689, doi. 10.3390/cancers13112689
- By:
- Publication type:
- Article
Dickkopf-2 (DKK2) as Context Dependent Factor in Patients with Esophageal Adenocarcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 451, doi. 10.3390/cancers12020451
- By:
- Publication type:
- Article
ASO Visual Abstract: Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7422, doi. 10.1245/s10434-023-13643-9
- By:
- Publication type:
- Article
High NANOG expression correlates with worse patients' survival in esophageal adenocarcinoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11146-0
- By:
- Publication type:
- Article
Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75085-7
- By:
- Publication type:
- Article